Detalhe da pesquisa
1.
The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir.
Arch Virol
; 169(2): 29, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216710
2.
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
PLoS Pathog
; 17(5): e1009527, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956888
3.
Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
J Infect Dis
; 221(3): 346-355, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309975
4.
Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes.
Clin Infect Dis
; 71(4): 971-981, 2020 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31538644
5.
Suppression of RIP3-dependent necroptosis by human cytomegalovirus.
J Biol Chem
; 290(18): 11635-48, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25778401
6.
Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses.
J Virol
; 88(1): 120-30, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24131715
7.
Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes.
J Virol
; 87(15): 8651-64, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23720731
8.
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.
Sci Rep
; 14(1): 9830, 2024 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38684712
9.
Safety and immunogenicity of a booster dose of S-268019-b: Interim findings of a Phase 3, open-label clinical study in Japan.
Vaccine X
; 15: 100390, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822891
10.
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults.
Vaccine
; 41(11): 1834-1847, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572603
11.
A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component.
Front Immunol
; 14: 1116238, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891311
12.
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings.
Vaccine
; 40(27): 3721-3726, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606235
13.
Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques.
Vaccine
; 40(52): 7520-7525, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372670
14.
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study.
Vaccine
; 40(32): 4328-4333, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738968
15.
Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model.
Commun Biol
; 5(1): 1026, 2022 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171475
16.
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Vaccine
; 40(31): 4231-4241, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691872
17.
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Sci Rep
; 12(1): 20861, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460696
18.
Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil.
Influenza Other Respir Viruses
; 15(3): 389-395, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099886
19.
Carryover effects of baloxavir acid in human nasopharyngeal/pharyngeal swabs on infectious titer testing of influenza virus.
Influenza Other Respir Viruses
; 14(3): 353-357, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31994309
20.
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Sci Rep
; 14(1): 2599, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297027